AIDS Alert Archives – August 1, 2011
August 1, 2011
View Issues
-
Is there a doctor in the house? Shortage threatens HIV gains
There have been recurrent warnings that the United States is facing an HIV clinician shortage that could lead to a critical setback in the fight against AIDS. -
CDC trial: HIV PrEP works for heterosexuals
A landmark new CDC study dubbed TDF2 along with a separate trial released July 13, 2011 provide the first evidence that a daily oral dose of antiretroviral drugs used to treat HIV infection can reduce HIV acquisition among uninfected individuals exposed to the virus through heterosexual sex, the Centers for Disease Control & Prevention reports. -
National groups look to increase HIV doctors
Medical schools, HIV organizations, foundations, and the federal government will need to work together to avert a crisis as the supply of HIV-trained physicians dwindles, experts say. -
Physician "grew her own" HIV doc for practice
At least one HIV physician is not waiting for a federal or foundation-based solution to her personal HIV doctor shortage problem. Instead she has tackled the problem by "growing" her own HIV clinician. -
IAS 2011: AIDS at a watershed moment
The global AIDS response is at "a scientific watershed" that includes both dramatic recent advances against HIV and the formidable challenge of extending the benefits to impoverished nations. -
IAS: `Game changers' must be widely adopted
Researchers and clinicians are achieving game-changing results that are revolutionizing HIV prevention, care and treatment, Michel Sidibé, Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS) said recently in Rome at the IAS 2011 conference. -
FDA Notifications: HCV virus protease inhibitor is approved
On May 23, 2011, the Food and Drug Administration approved telaprevir (Incivek®), an hepatitis C virus (HCV) protease inhibitor. Telaprevir is the second direct acting antiviral drug against the hepatitis C virus to be approved.